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Abstract
Objective: The objective of this selective EBM review is to determine the effect of cocoa
flavanol consumption on cognitive behavior.
Study Design: Systematic review of three English language randomized, double blind, controlled
clinical trials published in 2010, 2011, and 2012.
Data sources: Three double blind randomized controlled trials comparing cognitive function after
consumption of drinks with high cocoa flavanol level were found using PedMed and Ovid.
Outcomes measured: Cognitive function was measured by various tests: a Cognitive Demand
Battery composed of two serial subtraction tasks, a Rapid Visual Information processing task, a
mental fatigue scale over 1 hour, the Mini Mental Status Examination, Trail Making Test, a
verbal fluency test, and a visual spatial working memory for location task.
Results: The RCT conducted by Desideri et al found the groups who consumed cocoa flavanol
had a significantly reduced time to complete the Trail Making test and significantly improved
verbal fluency test scores compared with the control. The study did not find significant change in
the Mini Mental State examination after cocoa flavanol ingestion. The Scholey et al study found
there there were variable changes in the Cognitive Battery Demand testing. With Serial Three
subtractions there were statistically significant effects of cocoa flavanol with a greater number
correct and fewer errors compared with the control. With the Serial Sevens task and Rapid
Visual Information processing tasks there were not any significant differences between the
control and the group who consumed cocoa flavanol. The Field et al study showed participants
who consumed cocoa flavanol had a statistically significant improvement on visual spatial tasks
and a faster reaction time than the control.
Conclusions: The evidence is inconclusive whether there is an effect of cocoa flavanols on
cognitive function. Future studies collecting data on the effect of habitual consumption of cocoa
flavanol on cognitive performance could prove most relevant for preventing age related cognitive
changes. Two of the studies sampled young adults; compiling more trials with adult participants
would be beneficial to assessing whether cocoa flavanols can prevent or improve age related
cognitive function decline.
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Introduction:
Cognition is defined as conscious mental activities: the activities of thinking,
understanding, learning, and remembering. Cognitive impairment is the state of individuals who
are memory impaired but well-functioning and without evidence of dementia.1 Cocoa flavanol
ingestion is associated with increased cerebral blood flow and brain activation and have been
proposed to be effective in reversing age related declines in neurocognitive function by
increasing the number and strength of the connections between neurons, reducing neuronal loss,
and through their ability to interact with the molecular architecture of the brain responsible for
memory. 1 This paper evaluates three double blind, randomized, controlled trials comparing
cognitive function after the ingestion of cocoa flavanols.
This topic is relevant to PA practice because the US population continues to live longer
with each generation; therefore, maintaining and enhancing cognitive function is of importance
as there are commonly age related cognitive declines in attention and short term memory. A
population based study found 16% of individuals aged 70-89 without dementia to have mild
cognitive impairment.2 Mild cognitive impairment puts individuals at increased risk of
developing dementia and Alzheimer’s disease. In 2013, Alzheimer’s disease is expected to cost
the US $203 billion in health care costs. 3 Increasing cognitive ability is of relevance to all age
groups and is beneficial in daily activities and occupational tasks. Screening for cognitive
function changes is part of the criteria for Medicare’s yearly wellness exam. 4
There remains to be much that in unknown in regard to cognitive function impairment as
it is difficult to predict and is highly variable between individuals. There is no current effective
prevention or treatment. Flavonoids, found in many plant based foods, may be associated with a
decreased risk of incident dementia and with lower prevalence of cognitive impairment, a better
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cognitive evolution over a 10 year period, and better dose dependent performance of several
cognitive abilities in elderly subjects. 1
While there is not yet a standard cure or treatment of cognitive impairment there are
dozens of dietary supplements marketed as enhancing cognitive function such as gingko biloba,
phosphatidylcholine, and ginseng. 4 Currently, there are no effective preventive strategies for
cognitive decline. Most research points to modifiable lifestyle factors, such as poor diet and
physical and cognitive inactivity, as being associated with the risk of dementia. Therefore,
prevention of cognitive decline is aimed at treating heart disease risk factors such as elevated
cholesterol, obesity, diabetes, and hypertension. 5
Research has not yielded a cure for cognitive function decline but many natural products
have been proposed as able to enhance cognition. Cocoa flavanol ingestion is associated with
increased cerebral blood flow and brain activation so cocoa flavanols may be a safe and natural
way to increase attention, short term memory, and cognitive function. 6
Objective:
The objective of this selective EBM review is to determine the effect of cocoa flavanol
consumption on cognitive behavior.
Methods:
The three studies utilized were randomized, double blind, controlled clinical trials. The
populations ranged from 18-30 years old for two of the studies, and alternatively an elderly
population with mild cognitive impairment was observed in one study. The interventions studied
in all three RCTs were the consumption of drinks with a high cocoa flavanol level, in
comparison to groups that consume a drink with a low level of cocoa flavanol. The main
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outcome measured was cognitive function and secondary outcomes included changes in blood
pressure and changes in mood.
To find data sources I searched PubMed and Ovid with the key words “cocoa flavanol” and
“cognitive function.” All articles were published in peer-reviewed journals in the English
language. Articles were selected based on relevance to clinical topic of interest, dates in which
they were published, and whether they represented patient-oriented evidence that matters. To be
considered as adequate studies to be reviewed, experimentation was required to involve
randomized, controlled and double blind clinical trials published after 1996. Exclusion criteria
included patients diagnosed with dementia. The summary of statistics reported include: p-values
and F (ANOVA).
Table 1: Demographics & Characteristics of included studies
Study Type
# Age (yrs) Inclusion Criteria Exclusion
Pts
Criteria
Desideri Double90 “elderly” Participants were
1
(2012) blind
recruited among
randomized
patients referred to
parallel arm
the Alzheimer unit
of the University of
study
L’Aquila Geriatric
Division for mild
cognitive
impairment (MCI),
as diagnosed
according to the
revised Peterson
criteria.

W/D Interventions

The selection 3
criteria for the
population
included that
none of the
participants
was obese
(BMI >30
kg/m2), a
current
smoker, or on
statin
treatment.

Consumption of a
drink containing a
high level (~990
mg per serving) of
cocoa flavanols
once daily for 8
weeks or
consumption of a
drink containing
an intermediate
(~520 mg per
serving) or low
(~45 mg per
serving) level of
cocoa flavanols
once daily for 8
weeks
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Scholey Randomized 30 18-35 y/o Undergraduate and
(2010) 6 , controlled,
(mean
graduate students
doubleage: 21.9) that were in good
blinded,
health, nonbalanced,
smokers, and who
three period
abstained from
cross-over
cocoa, alcohol, and
caffeine
study
consumption for a
minimum of 12h
prior to testing
session.

Patients who 0
used illicit
drugs and over
the counter or
prescription
medication

Consumption of a
drink containing
520 mg or 994 mg
of cocoa flavanol

Field
RCT
(2011) 7

Participants
0
were excluded
if they had
medically
restricted diet
or any kind of
ongoing
illness.

Consumption of
dark chocolate
containing 720mg
of cocoa flavanol

30 18-25 y/o Participants were
recruited from the
School
Undergraduate
Research panel and
had normal visual
acuity or corrected
to normal with
glasses.

Outcomes measured:
The main outcome measured was cognitive function in all three RCTs. In the Desideri et
al study, cognitive function after consumption of cocoa flavanol in individuals with mild
cognitive impairment was measured by the Mini Mental Status Examination, Trail Making Test,
and a verbal fluency test. Desideri et al measured blood pressure and various metabolic
parameters as secondary outcomes. Scholey et al assessed cognitive function with a Cognitive
Demand Battery composed of two serial subtraction tasks, and used the Spielberger state anxiety
questionnaire to assess anxiety symptoms. Field et al tested each participant at a high and low
cocoa flavanol level on separate occasions to assess cognitive function. Field et al assessed
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cognitive function with various tests including a visual spatial working memory task and a
choice reaction time test designed to engage processes of sustained attention and inhibition.
Results:
The RCT conducted by Desideri et al assessed the impact of regular (once daily) cocoa
flavanol consumption on cognitive function in individuals with mild cognitive impairment in an
8 week study. Participants were recruited among those referred to the Alzheimer unit of the
University of L’Aquila Geriatric Division for mild cognitive impairment, and selection criteria
included that none of the participants were obese, a current smoker, or under statin treatment.
The participants were divided into a high, intermediate, and low level of cocoa flavanol
ingestion. The groups were comparable in terms of sex, age, cardiovascular risk factors, and
pharmacological treatments. The main measurement was cognitive function as assessed by the
Mini Mental State Examination, Trail Making Test, and a verbal fluency test. Two participants in
the intermediate group discontinued the study after 4 weeks because of personal reasons and one
participant in the low ingestion group discontinued after 2 weeks because of reported gastric
discomfort. All 3 were followed up during the entire study period and data was included
according to intention to treat procedure. Overall compliance was 99.4% at week 8 and
adherence to protocol was evaluated at each visit by a questionnaire checklist. The Mini Mental
State Examination score did not change significantly between the 3 groups during the study
(p=0.13). The time to complete the Trail Making test significantly reduced in the groups who
consumed high and intermediate levels of cocoa flavanol but did not change in the low cocoa
flavanol level group (Table 2). Verbal fluency test scores significantly improved in the groups
with high and intermediate cocoa flavanol ingestion (Table 3). Systolic and diastolic blood
pressures significantly changed during the study period with significant reduction in the high and
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intermediate level flavanol groups. Blood pressure did not change in the group who consumed a
low level of flavanol (p<0.0001).
Table 2: Change in time to complete Trail Making Test from week 1 to week 8 (calculated as
week 8 time minus week 1 time) among groups ingesting high, intermediate, or low cocoa
flavanol amounts.
Amount of cocoa flavanol consumed

Change in time (seconds)

P value

High (990mg)
Intermediate (520mg)

-14.3±4.2
-8.8±3.4

<.0001
<.0001

Low (45mg)

+1.1±13

0.65

Table 3: Verbal fluency score among groups ingesting high, intermediate, or low cocoa flavanol
amounts.
Amount of cocoa flavanol consumed

Verbal fluency (words/60 seconds)

P value

High (990mg)
Intermediate (520mg)

8.0±5.3
5.1±3.1

<.0001
<.0001

Low (45mg)

1.2±2.7

0.014

Table 4: Blood pressure change from week 1 to week 8 among groups ingesting high,
intermediate, or low cocoa flavanol amounts.
Amount of cocoa
flavanol consumed

Systolic BP change
(mm Hg)

P value

Diastolic BP
(mm Hg)

P value

High (990mg)
Intermediate (520mg)

-10.1±9.2
-8.2±8.5

<.0001
<.0001

-4.8±5.3
-3.4±7.0

<0.0001
<0.0001

Low (45mg)

-1.4±9.4

0.16

-0.9±6.8

0.14

The RCT conducted by Scholey et al compared consumption of a drink containing
520mg and 994mg cocoa flavanol and a control drink. The study used healthy undergraduate
students aged 18-35 years old as subjects and conducting the study on four separate occasions at
least three days apart for each subject. To assess compliance, salivary caffeine levels were
measured in order to confirm adherence to caffeine abstinence instructions. To test for baseline
differences between the groups which may have skewed change from baseline scores, prior to
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the primary statistical analysis, all pre-dose baseline measures were subjected to one way
repeated measures ANOVAs. There was not a significant effect of cocoa flavanol consumption
with the Spielberger state anxiety questionnaire (F<1 in all cases), and there were variable
changes in the Cognitive Battery Demand testing. With Serial Three subtractions there were
statistically significant effects of drink consumption on the number of Serial Threes correct and
the number of errors with a greater number correct (F=18.6, p <.001) and fewer errors (F=4.67,
p=0.01) at 20 minutes following 994mg of cocoa flavanol compared with the control. With the
Serial Sevens task there were not any significant differences between the control and
consumption of cocoa flavanol (F<1, p>0.1). With the Rapid Visual Information processing tasks
(RVIP) there were no significant treatment effects on accuracy (F=1.13, p>0.1) but participants
were significantly faster (F=0.66, p=0.03) at the task. Excluded from the study were patients who
used illicit drugs or prescription or over the counter medications so as to avoid results that were
skewed by interactions with medications or illicit drugs.
The RCT by Field et al was conducted in the School of Psychology and Clinical
Language Sciences at the University of Reading and included 30 participants between 18-25
years old who were recruited from the Undergraduate Research Panel and received course credit
for their participation. The study compared participants visual spatial working memory with and
without cocoa flavanol supplementation and found a significant difference between the two
conditions (F=3.41, p=0.05). Results showed that with high cocoa flavanol ingestion the groups
had a greater percent correct on visual spatial tasks (Table 5). In the reaction time assessment the
participants to consume a high cocoa flavanol drink had a faster reaction time (Table 5) than the
control. The study excluded participants who reported having medically restricted diet or any
kind of ongoing illness, and all participants had normal visual acuity or acuity corrected to
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normal by glasses. For 24 hours prior to study days and during the 2 hour interval between
consumption and testing participants were asked to avoid consuming a list of foods and drinks
containing flavonoids , as well as alcohol and caffeine. To increase compliance researchers told
participants that a cheek swab would be collected and analyzed to check conformity to
restrictions, however the swab was collected and not analyzed.
Table 5: Visual spatial and reaction time tasks comparing high cocoa flavanol ingestion and
control groups.
Amount of cocoa flavanol consumed
Visual spatial (% correct)
Reaction time (ms)

High CF

Control

87.13±9.32
538±149

83.51±11.16
557±85

In regards to safety, all three studies did not find evidence of any relevant adverse effects.
The studies did not quantify adverse effects as there were not any consistent adverse findings to
be evaluated. A participant in one study, Desideri et al, reported nonspecific gastric discomfort.
Discussion:
The data from Desideri et al found cognitive performance was improved with cocoa
flavanol consumption and blood pressure, both systolic and diastolic, was decreased. The study
was a 2 month intervention so the extent and duration of cognitive benefits, and their impact on
mild cognitive impairment are not known. It is also unclear whether the observed benefits in
neurocognition are a result of the cocoa flavanols themselves or a “secondary effect related to
general improvements in cardiovascular function or health.” 1 A limitation was that the study
population included subjects without known cardiovascular disease and therefore was not
representative of all subjects with mild cognitive impairment. Overall the results provide
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evidence that flavanol containing foods could be an effective dietary approach for improving
aspects of cognitive dysfunction.
The results of Scholey et al demonstrate that the acute consumption of cocoa flavanol can
improve cognitive performance during cognitive processing in healthy young participants.
Compared with the nutrient matched, low flavanol control drink, some improvements in
cognition were found after consumption of both the 520mg and 994 mg cocoa flavanol drinks,
and interestingly the 520mg drink was most beneficial. The data suggests that the Serial Threes
task draws on different neurocognitive substrates than the Serial Sevens. It is unclear why the
520mg drink led to better cognitive function with a lower level of cocoa flavanol than the 994mg
drink. The study was limited by the population’s small age range, between 18 and 35 years old,
and small sample size of 30 individuals.
The results of Field et al demonstrate that performance on tests of visual system function
in healthy young adults can be improved by acute consumption of cocoa flavanol. A reduction in
time required to integrate visual motion could be beneficial in everyday tasks like driving. There
are reasons to predict that the chronic effects of cocoa flavanol supplementation on visual
function will be larger than the acute effects discussed in the research by Field et al. Dietary
flavonoids are neuroprotective, enhance the endothelial function, and suppress inflammatory
processes, all of which would likely be beneficial for the retina and visual cortex. 7 Rat models
suggest that epigallocatechin gallate, a flavonoid from green tea, has a protective effect on the
neural layer of the retina and accelerates recovery from various insults to the retina. 7 The
findings from Field et al are limited by their basis on visual function in young adults and their
findings could be extended to investigate the effects of cocoa flavanol on vision in older adults
since decline in visual processing is associated with aging.
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Research has previously shown that flavanol rich chocolate and cocoa products may have
a small but statistically significant effect in lowering blood pressure by 2-3 mm Hg in the short
term. 8 Yet, the literature notes that long-term trials are needed to determine whether or not blood
pressure is reduced on a chronic basis by daily ingestion of cocoa. Research is also needed to
determine the effect of cocoa flavanol on cardiovascular events and to assess potential adverse
effects associated with chronic ingestion of cocoa products. 8
Conclusion:
The evidence is inconclusive whether there is an effect of cocoa flavanols on cognitive
function. It would be of great interest to explore the chronic effects of cocoa flavanol ingestion
and comparing them to those elicited acutely as in the discussed studies. Future studies collecting
data on cocoa flavanol’s effect on cognitive performance with habitual consumption could prove
most relevant for preventing age related cognitive changes. Two of the studies sampled young
adults between 18 and 35 years old but compiling more trials with adult participants would be
beneficial to assessing whether cocoa flavanols can prevent or improve age related cognitive
function decline. It would also be interesting to compare caffeine ingestion to cocoa flavanol
ingestion in future trials to rule the possibility that the caffeine ingredient in cocoa is contributing
to its positive effects.
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